Method for delaying premature ovarian failure and treating osteoporosis by using umbilical cord blood stem cell infusion combined with autologous peripheral blood stem cells

A technology of peripheral blood stem cells and cord blood stem cells, applied in the field of treatment of osteoporosis, can solve the problems of short duration of curative effect and slow effective time.

Inactive Publication Date: 2018-12-21
东营凤起生物科技发展有限公司
View PDF7 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Although the results of some clinical trials have initially shown that stem cells are effective in treating aging degenerative diseases and have certain therapeutic effects, the effective time is relati

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Method for delaying premature ovarian failure and treating osteoporosis by using umbilical cord blood stem cell infusion combined with autologous peripheral blood stem cells
  • Method for delaying premature ovarian failure and treating osteoporosis by using umbilical cord blood stem cell infusion combined with autologous peripheral blood stem cells
  • Method for delaying premature ovarian failure and treating osteoporosis by using umbilical cord blood stem cell infusion combined with autologous peripheral blood stem cells

Examples

Experimental program
Comparison scheme
Effect test

specific Embodiment

[0027] Specific example: 117 people were treated with umbilical cord blood stem cell infusion combined with autologous peripheral blood stem cells, their physical fitness was measured respectively, and the physical condition data of the injection of umbilical cord blood cytokines were compared to obtain the data shown in Table 1:

[0028] Table 1: Physical fitness measurement data

[0029]

[0030] Among the 117 people who participated in the treatment, 43 people suffered from osteoporosis, and the treatment method provided by the present invention was used to treat for 7 months, and the changes in bone density were observed in 1 month, 3 months, 5 months and 7 months respectively. For statistics, the ultrasonic bone densitometer used is AOS-100NW of Japan ALOA Company, and the data are shown in Table 2:

[0031] Table 2 Statistical table of changes in bone mineral density in patients with osteoporosis after treatment

[0032]

[0033] figure 2 Statistical chart of bo...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses a method for delaying premature ovarian failure and treating osteoporosis by using umbilical cord blood stem cell infusion combined with autologous peripheral blood stem cells.The method comprises the following steps: step one, preparing umbilical cord blood cytokines, and preparing umbilical cord blood stem cells; step two, initiating autologous peripheral blood stem cells; step three, infusing the umbilical cord blood cytokines into blood to enable the umbilical cord blood cytokines to be combined with the autologous peripheral blood stem cells for treatment; step four, regularly following changes of indicators of curers. According to the method for delaying the premature ovarian failure and treating the osteoporosis by using the umbilical cord blood stem cell infusion combined with the autologous peripheral blood stem cells, the autologous stem cells have no immune rejection and can survive for a long time, but the activity of the cells is insufficient; theliving environment of the autologous stem cells is improved by the method of inputting cytokines, the combined use of the two enhances the complementary advantages, no side effect exists during a process of delaying the premature ovarian failure and treating the osteoporosis, and a damaged tissue is repaired by inputting the umbilical cord blood cytokines and the autologous peripheral blood stem cells to restore organ functions to delay the premature ovarian failure and treat the osteoporosis.

Description

technical field [0001] The invention relates to the field of biotechnology, and more specifically relates to a method for delaying premature ovarian failure and treating osteoporosis by adopting umbilical cord blood stem cell infusion combined with autologous peripheral blood stem cells. Background technique [0002] As we all know, aging is an activity that accompanies the occurrence and development of life, and it is the process of loss and degeneration of the body from constituent materials, tissue structure to physiological functions. The aging process continues to occur from the fertilized egg to death, and it is only at a certain stage that the characteristics of aging appear more clearly. The physiological changes in the aging process of the human body are mainly reflected in the loss of body tissue cells and constituent substances, the slowdown of the body's metabolic rate, and the decline of body and organ functions. Aging is inevitable, but it is possible to delay...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K38/19A61P15/08A61P19/10C12N5/0775A61K35/51
CPCA61K35/51A61K38/193A61P15/08A61P19/10C12N5/0665A61K2300/00
Inventor 李霞刘晓芳韩萍张妍李闰洲左钧
Owner 东营凤起生物科技发展有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap